Disease | Salivary EV markers | Alteration | Clinical significance | Ref. |
---|---|---|---|---|
Periodontitis | miR-140-5p, miR-146a-5p, miR-628-5p | Increased | Diagnostic markers for periodontitis | [52] |
miR-223-3p | Decreased | Diagnostic markers for periodontitis | [53] | |
miR-125a-3p | Increased | Diagnostic markers, correlates with pocket depth | [54] | |
Immune-related proteins | Increased | Diagnostic markers, involvement in immune responses | [55] | |
CD9, osterix, TNFα | Increased: CD9, TNFα Decreased: osterix | Diagnostic markers for periodontitis | [56] | |
LPS+ outer membrane vesicles, m5C methylation, pathogens | Increased | Diagnostic markers for periodontitis | [57] | |
CD9, CD81 | Decreased | Correlates with periodontal disease severity | [58] | |
PD-L1 mRNA | Increased | Correlates with periodontal disease severity | [59] | |
C6, miR-142, miR-144 CD81, TSG101 | Increased: C6, miR-142, miR-144 Decreased or unchanged: CD81, TSG101 | Potential biomarkers for monitoring therapeutic efficacy | [60] | |
Oral cancer | Size, morphology, contents | Altered | Diagnostic markers for oral cancer | |
miR-302b-3p, miR-517b-3p, miR-512-3p, miR-412-3p | Increased | Diagnostic markers for oral cancer | [67] | |
miR-24-3p | Increased | Diagnostic marker for oral cancer | [68] | |
miR-1307-5p | Increased | Diagnostic and prognostic markers for oral cancer | [69] | |
CD81, CD9, CD63 | Increased: CD63 Decreased: CD81, CD9 | Diagnostic marker for oral cancer | [71] | |
the proteomic pattern | Altered | Diagnostic marker for oral cancer | ||
Alix | Increased | Diagnostic and prognostic markers for oral cancer | [73] | |
HPV DNA, glycolytic enzymes | Increased | Diagnostic marker for oral cancer | [75] | |
salivary microvesicles | Increased | Diagnostic and prognostic markers for oral cancer | [76] | |
EGFR+ EVs | Increased | Diagnostic and prognostic markers for oral cancer | [77] | |
Oral lichen planus | miR-4484 | Increased | Biomarker for monitoring malignant transformation | [78] |